Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclometasone dipropionate added to antibiotics for acute rhinosinusitis
2011-001459-35Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute rhinosinusitis (ARS) comparing Beclometasone dipropionate + antibiotic therapy with Placebo + antibiotic therapy (2 arms). Primary endpoint: Clinical success rate. Started Dec 2012; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on 2011-001459-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001459-35.